DNA methylation patterns affecting tumor suppressors, exemplified by BRCA1, RASSF1, and PITX2, have consistently been associated with aggressive behavior and poor outcomes in ER-positive and HER2-negative tumors [138]. The gene discussed is BRCA1; the disease is neoplasm.